Yuting Zhang

915 total citations
49 papers, 705 citations indexed

About

Yuting Zhang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yuting Zhang has authored 49 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Yuting Zhang's work include Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (5 papers) and Aquaculture disease management and microbiota (4 papers). Yuting Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (5 papers) and Aquaculture disease management and microbiota (4 papers). Yuting Zhang collaborates with scholars based in China, United States and Czechia. Yuting Zhang's co-authors include Xin Lü, Zhigang Zhou, Guoqiang Liu, Miaomiao Sun, Wenshu Liu, Xinyi Wu, Yalin Yang, Li Xu, Chubin Qin and Leslie Louie and has published in prestigious journals such as Biomaterials, Cancer Research and Journal of Virology.

In The Last Decade

Yuting Zhang

45 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting Zhang China 16 340 211 122 82 69 49 705
Chun Liu China 18 384 1.1× 215 1.0× 24 0.2× 85 1.0× 66 1.0× 64 771
Xiangyu Jin China 13 187 0.6× 238 1.1× 59 0.5× 11 0.1× 69 1.0× 37 593
Dong‐Gyun Lim South Korea 15 264 0.8× 288 1.4× 99 0.8× 18 0.2× 119 1.7× 47 930
Xuan Li China 19 628 1.8× 157 0.7× 87 0.7× 8 0.1× 64 0.9× 53 1.7k
Chuanbin Shen China 15 162 0.5× 284 1.3× 24 0.2× 13 0.2× 65 0.9× 37 809
Xizhong Zhang Canada 19 477 1.4× 316 1.5× 58 0.5× 22 0.3× 394 5.7× 41 1.1k
Pinegin Bv Russia 15 638 1.9× 340 1.6× 44 0.4× 26 0.3× 77 1.1× 70 1.0k
Leanne Peiser United Kingdom 12 805 2.4× 376 1.8× 97 0.8× 13 0.2× 77 1.1× 18 1.3k
Kentaro Miyamoto Japan 19 269 0.8× 477 2.3× 161 1.3× 45 0.5× 105 1.5× 39 1.1k
R D Stout United States 17 834 2.5× 249 1.2× 125 1.0× 53 0.6× 83 1.2× 37 1.4k

Countries citing papers authored by Yuting Zhang

Since Specialization
Citations

This map shows the geographic impact of Yuting Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Zhang more than expected).

Fields of papers citing papers by Yuting Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Zhang. The network helps show where Yuting Zhang may publish in the future.

Co-authorship network of co-authors of Yuting Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Zhang. A scholar is included among the top collaborators of Yuting Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Zhang. Yuting Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yingai, et al.. (2025). HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib. BMC Cancer. 25(1). 185–185. 2 indexed citations
3.
Jiang, Dan, Yining Sun, Yu Xia, et al.. (2025). Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming. Advanced Science. 12(34). e03690–e03690. 1 indexed citations
4.
Zhang, Yuting, Jing Yang, Shuo Wang, et al.. (2025). Single‐Cell Transcriptomic Analysis Reveals an Aggressive Basal‐Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 40(5). 1263–1273.
5.
Zhou, Wanting, et al.. (2024). CCDC59 alleviates bleomycin-induced inflammation and pulmonary fibrosis by increasing SP-B and SP-C expression in mice. International Immunopharmacology. 138. 112645–112645. 2 indexed citations
6.
Zhang, Yuting, Huan He, Lanying He, & Bing Shi. (2023). IL-6 Accelerates the Proliferation and Metastasis of Pancreatic Cancer Cells via the miR-455-5p/IGF-1R Axis. Cancer Biotherapy and Radiopharmaceuticals. 39(4). 255–263. 6 indexed citations
7.
Wu, Ming, Hao Li, Zhang Cao, et al.. (2023). Silk‐Gel Powered Adenoviral Vector Enables Robust Genome Editing of PD‐L1 to Augment Immunotherapy across Multiple Tumor Models. Advanced Science. 10(12). e2206399–e2206399. 20 indexed citations
9.
Chen, Hong, Shan Wang, Yuting Zhang, et al.. (2023). A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. Frontiers in Oncology. 13. 1209707–1209707. 2 indexed citations
10.
Zhang, Yuting, et al.. (2023). What role does PDL1 play in EMT changes in tumors and fibrosis?. Frontiers in Immunology. 14. 1226038–1226038. 9 indexed citations
11.
Zhang, Yuting, Wen Qin, Wenhui Zhang, Yi Qin, & You Lang Zhou. (2022). Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes. Clinical & Translational Oncology. 25(4). 959–975. 2 indexed citations
12.
Li, Peng, Peng Li, Ke Li, et al.. (2021). IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 679517–679517. 26 indexed citations
13.
Madka, Venkateshwar, Gaurav Kumar, Gopal Pathuri, et al.. (2021). Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Cancer Prevention Research. 14(11). 1009–1020. 6 indexed citations
14.
Zhang, Yuting, et al.. (2020). Human Isogenic Cell Line Models for Neutrophils and Myeloid-Derived Suppressor Cells. International Journal of Molecular Sciences. 21(20). 7709–7709. 9 indexed citations
15.
Zhang, Yuting, Guoqiang Liu, Miaomiao Sun, & Xin Lü. (2020). Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment. Cancer Biology and Medicine. 17(1). 32–43. 81 indexed citations
16.
Han, Fang, Hui Guo, Yuting Zhang, et al.. (2020). The cGAS-STING signaling pathway contributes to the inflammatory response and autophagy in Aspergillus fumigatus keratitis. Experimental Eye Research. 202. 108366–108366. 27 indexed citations
18.
Rao, Chinthalapally V., Yuting Zhang, Laura Biddick, et al.. (2016). Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1 −/+ Mice. Cancer Research. 76(3). 630–642. 19 indexed citations
19.
Zhang, Yuting, et al.. (2014). Aspergillus fumigatus triggers innate immune response via NOD1 signaling in human corneal epithelial cells. Experimental Eye Research. 127. 170–178. 41 indexed citations
20.
Han, Donghui, et al.. (2007). Assay of AVP, CRP, and LPS in leukemia. International Journal of Laboratory Hematology. 29(3). 185–189. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026